News Daily News Blood in Urine Carries Consequences for Patients on Antithrombotics Yael L. Maxwell October 09, 2017
Presentation Association Between Use of Antithrombotic Medication and Hematuria-Related Complications October 09, 2017
News Features COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict Todd Neale September 15, 2017
News Conference News ESC 2017 ESC Releases Revamped DAPT Guidance Focusing on Personalized Approach Todd Neale September 01, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2017 Caitlin E. Cox August 31, 2017
News Conference News ESC 2017 Dual Antithrombotic Approach in Patients With A-fib Undergoing PCI Boosted in RE-DUAL PCI Todd Neale August 27, 2017
News Conference News ESC 2017 COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease Todd Neale August 27, 2017
News Daily News Fibrinolytic Agents for STEMI: Meta-analysis Explores the Differences Todd Neale August 18, 2017
News Daily News Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI L.A. McKeown May 23, 2017
News Daily News ‘Forgotten’ Patients With Mechanical Heart Valves Undergoing PCI Pose Clinical Conundrum Todd Neale April 27, 2017
News Daily News Long-term MI Risk Among Stable CAD Patients: Some Clues From CORONOR Shelley Wood April 24, 2017
News Conference News ACC 2017 Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe Todd Neale March 18, 2017
News Daily News Rising Subdural Hematoma Rates Appear to Be Linked to Greater Use of Antithrombotics Todd Neale March 03, 2017
News Conference News CRT 2017 Higher Mortality Among TAVR Patients With Atrial Fibrillation Treated With Triple Therapy Michael O'Riordan February 20, 2017
News Daily News Rivaroxaban’s ‘Overwhelming’ Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS Todd Neale February 08, 2017
News Daily News Best Anticoagulant in the TAVR Patient With A-fib? Small Study Makes Case for Apixaban Michael O'Riordan January 03, 2017